Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Covington
Express Scripts
Fuji
Argus Health
Boehringer Ingelheim
Daiichi Sankyo
Deloitte
Queensland Health
Moodys

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021282

« Back to Dashboard

NDA 021282 describes MUCINEX, which is a drug marketed by Reckitt Benckiser and is included in three NDAs. It is available from twenty-five suppliers. There are three patents protecting this drug and three Paragraph IV challenges. Additional details are available on the MUCINEX profile page.

The generic ingredient in MUCINEX is dextromethorphan hydrobromide; guaifenesin. There are twenty-two drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; guaifenesin profile page.
Summary for 021282
Tradename:MUCINEX
Applicant:Reckitt Benckiser
Ingredient:guaifenesin
Patents:3
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 021282
Suppliers and Packaging for NDA: 021282
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MUCINEX guaifenesin TABLET, EXTENDED RELEASE;ORAL 021282 NDA walgreens 0363-0071 N 0363-0071-20
MUCINEX guaifenesin TABLET, EXTENDED RELEASE;ORAL 021282 NDA walgreens 0363-0071 N 0363-0071-40

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET, EXTENDED RELEASE;ORALStrength600MG
Approval Date:Jul 12, 2002TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Apr 28, 2020Product Flag?Substance Flag?Delist Request?
Patented Use:EXPECTORANT
Patent:➤ Try a Free TrialPatent Expiration:Apr 28, 2020Product Flag?YSubstance Flag?Delist Request?
Patented Use:EXPECTORANT
Patent:➤ Try a Free TrialPatent Expiration:Apr 28, 2020Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Accenture
UBS
McKesson
Chinese Patent Office
US Department of Justice
Teva
Fuji
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot